| Scientific Name | Dasatinib |
|---|---|
| Brand Name | Sprycel |
| Risk | Risk of (PAH) Pulmonary Arterial Hypertension. The association of BCR-ABL targeting Tyrosine Kinase inhibitors (TKIs) including SPRYCEL® (dasatinib) with the risk of hepatitis B virus reactivation . |
| Scientific Name | Dasatinib |
|---|---|
| Brand Name | Sprycel |
| Risk | Risk of (PAH) Pulmonary Arterial Hypertension. The association of BCR-ABL targeting Tyrosine Kinase inhibitors (TKIs) including SPRYCEL® (dasatinib) with the risk of hepatitis B virus reactivation . |
